News
1d
Zacks Investment Research on MSNNovavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should KnowNovavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...
15h
Zacks.com on MSNNovavax (NVAX) Ascends While Market Falls: Some Facts to NoteNovavax (NVAX) concluded the recent trading session at $6.41, signifying a +1.75% move from its prior day's close.
Shares of Novavax Inc. NVAX slid 7.68% to $6.49 Tuesday, on what proved to be an all-around poor trading session for the ...
Novavax, Inc. faces profitability challenges despite a promising tech platform, with uncertain revenue streams. Click for my ...
Novavax's experimental COVID-19-influenza combination and standalone influenza vaccines generated a strong immune response in ...
Novavax's combo and standalone flu vaccines showed strong immune responses and good safety in a Phase 3 trial of adults 65 ...
9d
Zacks.com on MSNNovavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on ItNovavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Novavax's experimental COVID-19-influenza combination and standalone influenza vaccines showed strong immune responses in ...
This was the stock's second consecutive day of losses.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results